Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses
10.1038/ni.1638
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Ermolaeva, M. A., Michallet, M.-C., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G., Tschopp, J., & Pasparakis, M. (2008). Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nature Immunology, 9(9), 1037–1046.

Authors 8
  1. Maria A Ermolaeva (first)
  2. Marie-Cécile Michallet (additional)
  3. Nikoletta Papadopoulou (additional)
  4. Olaf Utermöhlen (additional)
  5. Ksanthi Kranidioti (additional)
  6. George Kollias (additional)
  7. Jürg Tschopp (additional)
  8. Manolis Pasparakis (additional)
References 40 Referenced 231
  1. Wallach, D. et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331–367 (1999). (10.1146/annurev.immunol.17.1.331) / Annu. Rev. Immunol. by D Wallach (1999)
  2. Muppidi, J.R., Tschopp, J. & Siegel, R.M. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21, 461–465 (2004). (10.1016/j.immuni.2004.10.001) / Immunity by JR Muppidi (2004)
  3. Chen, G. & Goeddel, D.V. TNF-R1 signaling: a beautiful pathway. Science 296, 1634–1635 (2002). (10.1126/science.1071924) / Science by G Chen (2002)
  4. Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305–1308 (1998). (10.1126/science.281.5381.1305) / Science by A Ashkenazi (1998)
  5. Varfolomeev, E.E. & Ashkenazi, A. Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491–497 (2004). (10.1016/S0092-8674(04)00166-7) / Cell by EE Varfolomeev (2004)
  6. Hsu, H., Shu, H.B., Pan, M.G. & Goeddel, D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996). (10.1016/S0092-8674(00)80984-8) / Cell by H Hsu (1996)
  7. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003). (10.1016/S0092-8674(03)00521-X) / Cell by O Micheau (2003)
  8. Kelliher, M.A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297–303 (1998). (10.1016/S1074-7613(00)80535-X) / Immunity by MA Kelliher (1998)
  9. Ea, C.K., Deng, L., Xia, Z.P., Pineda, G. & Chen, Z.J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257 (2006). (10.1016/j.molcel.2006.03.026) / Mol. Cell by CK Ea (2006)
  10. Devin, A., Lin, Y. & Liu, Z.G. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4, 623–627 (2003). (10.1038/sj.embor.embor854) / EMBO Rep. by A Devin (2003)
  11. Tada, K. et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276, 36530–36534 (2001). (10.1074/jbc.M104837200) / J. Biol. Chem. by K Tada (2001)
  12. Yeh, W.C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954–1958 (1998). (10.1126/science.279.5358.1954) / Science by WC Yeh (1998)
  13. Hsu, H., Huang, J., Shu, H.B., Baichwal, V. & Goeddel, D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387–396 (1996). (10.1016/S1074-7613(00)80252-6) / Immunity by H Hsu (1996)
  14. Zheng, L. et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell. Biol. 26, 3505–3513 (2006). (10.1128/MCB.26.9.3505-3513.2006) / Mol. Cell. Biol. by L Zheng (2006)
  15. Jin, Z. & El-Deiry, W.S. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol. Cell. Biol. 26, 8136–8148 (2006). (10.1128/MCB.00257-06) / Mol. Cell. Biol. by Z Jin (2006)
  16. Schneider-Brachert, W. et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21, 415–428 (2004). (10.1016/j.immuni.2004.08.017) / Immunity by W Schneider-Brachert (2004)
  17. Schneider-Brachert, W. et al. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J. Clin. Invest. 116, 2901–2913 (2006). (10.1172/JCI23771) / J. Clin. Invest. by W Schneider-Brachert (2006)
  18. Cusson-Hermance, N., Khurana, S., Lee, T.H., Fitzgerald, K.A. & Kelliher, M.A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280, 36560–36566 (2005). (10.1074/jbc.M506831200) / J. Biol. Chem. by N Cusson-Hermance (2005)
  19. Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation. Nat. Immunol. 5, 503–507 (2004). (10.1038/ni1061) / Nat. Immunol. by E Meylan (2004)
  20. Schwenk, F., Baron, U. & Rajewsky, K. A Cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995). (10.1093/nar/23.24.5080) / Nucleic Acids Res. by F Schwenk (1995)
  21. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397–1411 (1996). (10.1084/jem.184.4.1397) / J. Exp. Med. by M Pasparakis (1996)
  22. Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457–467 (1993). (10.1016/0092-8674(93)90134-C) / Cell by K Pfeffer (1993)
  23. Lee, T.H., Shank, J., Cusson, N. & Kelliher, M.A. The kinase activity of Rip1 is not required for tumor necrosis factor-α-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279, 33185–33191 (2004). (10.1074/jbc.M404206200) / J. Biol. Chem. by TH Lee (2004)
  24. Pasparakis, M., Alexopoulou, L., Douni, E. & Kollias, G. Tumour necrosis factors in immune regulation: everything that's interesting is...new! Cytokine Growth Factor Rev. 7, 223–229 (1996). (10.1016/S1359-6101(96)00031-7) / Cytokine Growth Factor Rev. by M Pasparakis (1996)
  25. Pasparakis, M., Kousteni, S., Peschon, J. & Kollias, G. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell. Immunol. 201, 33–41 (2000). (10.1006/cimm.2000.1636) / Cell. Immunol. by M Pasparakis (2000)
  26. Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death–inducing signaling complex. Cell 85, 817–827 (1996). (10.1016/S0092-8674(00)81266-0) / Cell by M Muzio (1996)
  27. Lehmann, V., Freudenberg, M.A. & Galanos, C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165, 657–663 (1987). (10.1084/jem.165.3.657) / J. Exp. Med. by V Lehmann (1987)
  28. Gowen, B.B. et al. TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules. J. Immunol. 178, 5200–5208 (2007). (10.4049/jimmunol.178.8.5200) / J. Immunol. by BB Gowen (2007)
  29. Kawai, T. & Akira, S. Signaling to NF-κB by Toll-like receptors. Trends. Mol. Med. 13, 460–469 (2007). (10.1016/j.molmed.2007.09.002) / Trends. Mol. Med. by T Kawai (2007)
  30. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640–643 (2003). (10.1126/science.1087262) / Science by M Yamamoto (2003)
  31. Hsu, H., Xiong, J. & Goeddel, D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495–504 (1995). (10.1016/0092-8674(95)90070-5) / Cell by H Hsu (1995)
  32. Li, H., Kobayashi, M., Blonska, M., You, Y. & Lin, X. Ubiquitination of RIP is required for tumor necrosis factor α-induced NF-κB activation. J. Biol. Chem. 281, 13636–13643 (2006). (10.1074/jbc.M600620200) / J. Biol. Chem. by H Li (2006)
  33. Sato, S. et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304–4310 (2003). (10.4049/jimmunol.171.8.4304) / J. Immunol. by S Sato (2003)
  34. Michallet, M.C. et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28, 651–661 (2008). (10.1016/j.immuni.2008.03.013) / Immunity by MC Michallet (2008)
  35. Kontgen, F., Suss, G., Stewart, C., Steinmetz, M. & Bluethmann, H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5, 957–964 (1993). (10.1093/intimm/5.8.957) / Int. Immunol. by F Kontgen (1993)
  36. Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861–866 (2002). (10.1038/nature00820) / Nature by M Pasparakis (2002)
  37. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998). (10.1016/S1074-7613(00)80596-8) / Immunity by O Adachi (1998)
  38. Kelly, B.S., Levy, J.G. & Sikora, L. The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures. Immunology 37, 45–52 (1979). / Immunology by BS Kelly (1979)
  39. Alexopoulou, L., Pasparakis, M. & Kollias, G. Complementation of lymphotoxin α knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function. J. Exp. Med. 188, 745–754 (1998). (10.1084/jem.188.4.745) / J. Exp. Med. by L Alexopoulou (1998)
  40. Thome, M. et al. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8, 885–888 (1998). (10.1016/S0960-9822(07)00352-1) / Curr. Biol. by M Thome (1998)
Dates
Type When
Created 17 years, 1 month ago (July 20, 2008, 3:16 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 7:35 p.m.)
Indexed 2 weeks, 2 days ago (Aug. 6, 2025, 9:14 a.m.)
Issued 17 years, 1 month ago (July 20, 2008)
Published 17 years, 1 month ago (July 20, 2008)
Published Online 17 years, 1 month ago (July 20, 2008)
Published Print 16 years, 11 months ago (Sept. 1, 2008)
Funders 0

None

@article{Ermolaeva_2008, title={Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses}, volume={9}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni.1638}, DOI={10.1038/ni.1638}, number={9}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Ermolaeva, Maria A and Michallet, Marie-Cécile and Papadopoulou, Nikoletta and Utermöhlen, Olaf and Kranidioti, Ksanthi and Kollias, George and Tschopp, Jürg and Pasparakis, Manolis}, year={2008}, month=jul, pages={1037–1046} }